ENTITY
Takeda Pharmaceutical

Takeda Pharmaceutical (4502 JP)

220
Analysis
Health CareJapan
Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.
more
Refresh
23 Apr 2018 13:49

The Week That Was in NorthAsia@Smartkarma: Itochu/FamilyMart, Samsung, Suruga, & Renesas

Below is the full list of Japan/Korea related reports published last week on Smartkarma.Itochu Tender For FamilyMartTravis Lundy explained the...

Logo
176 Views
Share
22 Apr 2018 20:49

Takeda Sweetens Offer for Shire: Deal – You Win! No-Deal – You Win Too!

Takeda Pharmaceutical Co Ltd (4502 JP)'s revised April 20, 2018 proposal of £47 / share (~$197.4 / ADS), valuing Shire PLC (SHP LN) at ~$60b, is...

20 Apr 2018 18:16

Japan Pharmaceuticals: The Week that Was…

Nippon Shinyaku Co Ltd (4516 JP) @ ¥ 8,480 (up ~18% week-to-date) vs. our TP ¥ 8,600. We recommend booking profit at current levels. Takeda...

bullishShire PLC
20 Apr 2018 10:51

Shire Remains Undervalued as Takeda Weighs Higher Bid and Allergan Enters the Picture

Shire PLC (SHP LN) has released details of recent negotiations with Takeda Pharmaceutical Co Ltd (4502 JP), detailing three proposed (and rejected)...

Logo
135 Views
Share
17 Apr 2018 20:55

Takeda + Shire - Monetizing Shire’s Neuroscience Division Could Be the Key

CEO Christopher Weber has always been vocal about his willingness to strike a multi-billion-dollar deal, if need be, to put in place Takeda’s...

x